| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2005 | CN1668645A Methods and copositions for the treatment of ischemic reperfusion |
| 09/14/2005 | CN1668631A Fractionation of phytosterol esters in oil |
| 09/14/2005 | CN1668629A Modulation of the expression of genes dependent on STAT-1 |
| 09/14/2005 | CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/14/2005 | CN1668627A Process for producing glycoside |
| 09/14/2005 | CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor |
| 09/14/2005 | CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 09/14/2005 | CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 09/14/2005 | CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/14/2005 | CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/14/2005 | CN1668617A Process for the preparation of imidazo(1, 2-A)pyridine-3-acetamides |
| 09/14/2005 | CN1668615A Novel benzimidazole derivatives |
| 09/14/2005 | CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor |
| 09/14/2005 | CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 09/14/2005 | CN1668610A Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives |
| 09/14/2005 | CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/14/2005 | CN1668606A Oxazole derivatives and their use as insulin sensitizers |
| 09/14/2005 | CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
| 09/14/2005 | CN1668604A Novel anthracene derivatives and the use thereof as a medicament |
| 09/14/2005 | CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 09/14/2005 | CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 09/14/2005 | CN1668598A Use of chemotherapeutic agents |
| 09/14/2005 | CN1668594A New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain |
| 09/14/2005 | CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals |
| 09/14/2005 | CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1 |
| 09/14/2005 | CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/14/2005 | CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 09/14/2005 | CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/14/2005 | CN1668586A Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 09/14/2005 | CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 09/14/2005 | CN1668583A Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
| 09/14/2005 | CN1668580A Aminoacetonitriles derivant for controlling parasite |
| 09/14/2005 | CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 09/14/2005 | CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/14/2005 | CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress |
| 09/14/2005 | CN1668565A Substituted 1, 3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 09/14/2005 | CN1668561A Remedy |
| 09/14/2005 | CN1668336A Drug transport and delivery system |
| 09/14/2005 | CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine |
| 09/14/2005 | CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 09/14/2005 | CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 09/14/2005 | CN1668319A Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid |
| 09/14/2005 | CN1668318A Avian appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 09/14/2005 | CN1668313A Medicinal composition for drug-induced neuropathy |
| 09/14/2005 | CN1668312A Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 09/14/2005 | CN1668311A Method and composition for treating diabetes |
| 09/14/2005 | CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 09/14/2005 | CN1668309A Trimegestone and estrogens for treating post menopausal disorders |
| 09/14/2005 | CN1668307A New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2, 3-d]pyrimidine |
| 09/14/2005 | CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases |
| 09/14/2005 | CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 09/14/2005 | CN1668304A Crystalline 2, 5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| 09/14/2005 | CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/14/2005 | CN1668301A Process for producing coated preparation |
| 09/14/2005 | CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof |
| 09/14/2005 | CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting |
| 09/14/2005 | CN1668298A Antitumor compound and therapeutic uses thereof |
| 09/14/2005 | CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668294A Use of nefopam for the treatment of nausea or emesis |
| 09/14/2005 | CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/14/2005 | CN1668292A Soluble stable pharmaceutical composition for the administration of HIV protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of HIV |
| 09/14/2005 | CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 09/14/2005 | CN1668290A Modified amino acid for the inhibition of platelet aggregation |
| 09/14/2005 | CN1668289A Modafinil pharmaceutical compositions |
| 09/14/2005 | CN1668288A Compounds with antiparasitic activity and medicines containing same |
| 09/14/2005 | CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 09/14/2005 | CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea |
| 09/14/2005 | CN1668285A Lasofoxifene tablet and its coating |
| 09/14/2005 | CN1668284A Sustained release oral dosage forms of gabapentin |
| 09/14/2005 | CN1668283A Pharmaceutical compositions with improved dissolution |
| 09/14/2005 | CN1668282A Directly compressible formulations of azithromycin |
| 09/14/2005 | CN1668281A Nanoparticulate fibrate formulations |
| 09/14/2005 | CN1668278A Bioerodible film for ophthalmic drug delivery |
| 09/14/2005 | CN1668277A Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 09/14/2005 | CN1668213A Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 09/14/2005 | CN1668212A Compositions comprising lactoferrin |
| 09/14/2005 | CN1667416A Diagnostics and therapeutics for glaucoma |
| 09/14/2005 | CN1666998A Fucoidan and its use |
| 09/14/2005 | CN1666994A Zinc bismuth glycyrrhetate (compound) and preparation method thereof |
| 09/14/2005 | CN1666992A Medical use of catalpol and its homologs |
| 09/14/2005 | CN1666991A Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 09/14/2005 | CN1666986A Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use |
| 09/14/2005 | CN1666985A Medical use of andrographolidume and its derivatives and analogs |
| 09/14/2005 | CN1666984A Process for extracting epigoitrin from isatis root and use thereof |
| 09/14/2005 | CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 09/14/2005 | CN1666751A Prescription for treating type 2 diabetes and its preparing method |
| 09/14/2005 | CN1666749A Application of lucid ganoderma polysaccharide and spine date seed total flavone in preparing process of hypnotic and health caring product |
| 09/14/2005 | CN1666748A Oral formulation of adetphos |
| 09/14/2005 | CN1666747A Fructose injection of anti-tumor drug |
| 09/14/2005 | CN1666746A Laevulose injection of antiviral drug |
| 09/14/2005 | CN1666745A Drug composition for treating osteoporosis |
| 09/14/2005 | CN1666744A Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof |
| 09/14/2005 | CN1666743A 复方头孢克洛分散片 Compound Cefaclor tablet |
| 09/14/2005 | CN1666742A Combination therapy to treat hepatitis b virus |
| 09/14/2005 | CN1666741A Stable naloxone freeze dried powder injection and preparation technology thereof |
| 09/14/2005 | CN1666740A Application of tetrandrine and Fangchinoline in preparation of medicine for improving sleep and health products |
| 09/14/2005 | CN1666739A Application of Silibinin or its salts in preparation of medicine for treating coronary heart disease or strengthening the effect of coronary heart disease treatment |